Skin cutaneous melanoma (SKCM) is a highly deadly form of skin cancer, with increasing global incidence. Smoking has been identified as a factor associated with poorer outcomes in melanoma patients.
This article discusses the potential biological pathways, specifically Alpha5-nAChR/ADAM10 signaling, that may mediate the effects of nicotine on melanoma progression, emphasizing the importance of understanding these mechanisms for public health strategies.